Recommendations on the use of everolimus in lung transplantation
A De Pablo, F Santos, A Solé, JM Borro… - Transplantation …, 2013 - Elsevier
The antiproliferative effect of everolimus provides a therapeutic option in the
immunosuppression therapy of lung transplantation, by reducing both the risk of acute …
immunosuppression therapy of lung transplantation, by reducing both the risk of acute …
Relationship between sRAGE and eotaxin-3 with CRP in hypertensive patients at high cardiovascular risk.
C Falcone, MP Buzzi, S Bozzini, C Boiocchi… - Journal of …, 2013 - europepmc.org
Background Cardiovascular disease (CVD) is the leading cause of death in Western
countries and is highly prevalent in patients with kidney disease. Traditional risk factors for …
countries and is highly prevalent in patients with kidney disease. Traditional risk factors for …